ANNUAL REPORT 2012 - TiGenix
ANNUAL REPORT 2012 - TiGenix
ANNUAL REPORT 2012 - TiGenix
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
- Partnering of Cx601 (i.e. finding a<br />
partner for the co-development and/or<br />
commercialization of Cx601 in different<br />
regions); and<br />
- Monetizing of some assets, such as the<br />
Dutch manufacturing facility (which was<br />
constructed by the Company in a building<br />
leased under a long-term lease contract<br />
running until July 2029).<br />
continue the Company’s operations for the<br />
next twelve months.<br />
In accordance with Article 96, 6° of the<br />
Belgian Companies Code, taking into<br />
account two consecutive financial years of<br />
losses, the Board of Directors has decided,<br />
after consideration, to apply the valuation<br />
rules assuming “going concern”, for the<br />
reasons set out above.<br />
According to the budget, the effective and<br />
timely realization of the above assumptions<br />
of the action plan will generate sufficient<br />
additional cash to continue the Company’s<br />
operations during the next twelve months.<br />
However, at this moment it is uncertain<br />
whether the above assumptions will be<br />
realized timely. There is a risk that the action<br />
plan will not generate sufficient additional<br />
cash, as a result of the non-realization or only<br />
partly realization of one or more assumptions.<br />
There is also a risk that, even if most of<br />
the assumptions would be realized, this<br />
realization will happen too late, so that the<br />
necessary additional cash is not generated<br />
timely to continue the Company’s operations<br />
for the next twelve months.<br />
However, if the execution of the above action<br />
plan would not or not timely generate sufficient<br />
additional cash, the Board of Directors intends<br />
to explore the option of obtaining additional<br />
dilutive funding (i.e. a capital increase) or nondilutive<br />
funding.<br />
Notwithstanding the described uncertainties,<br />
the Board of Directors is confident that<br />
the action plan described above, in<br />
combination with, if needed, additional<br />
dilutive funding (i.e. a capital increase), will<br />
timely generate sufficient additional cash to<br />
Since the Company is currently able to satisfy<br />
all financial liabilities and is able to fulfil all<br />
payments, the Board of Directors is of the<br />
opinion that the continuity of the Company is<br />
not threatened.<br />
9. Conflicts of interest<br />
In <strong>2012</strong>, during 3 Board meetings, decisions<br />
were taken that required the application of<br />
the conflict of interests procedure pursuant<br />
to Article 523 of the Belgian Companies<br />
Code. The relevant parts of the minutes are<br />
copied below.<br />
Meeting of the Board of Directors<br />
of January 23, <strong>2012</strong><br />
“Introduction<br />
The chairman opened the meeting and<br />
explained that the board meeting was held<br />
at the request of Gil Beyen BVBA, represented<br />
by Gil Beyen.<br />
The latter has proposed to scale down its role<br />
in the Company to a half-time role, thereby<br />
permitting it to take up other commitments<br />
vis-à-vis other companies as well.<br />
Going forward, the main focus of Gil Beyen<br />
BVBA, represented by Gil Beyen, would be on :<br />
192 <strong>TiGenix</strong> I annual report <strong>2012</strong>